Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × lorlatinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Recurrence 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Astrocytoma 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

Carboplatin 5 pembrolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 fludarabine phosphate 2 Taxes 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Paclitaxel 2 Cyclophosphamide 2 Biopsy 2 veliparib 1 methoxyamine 1 fludarabine 1 durvalumab 1 dapagliflozin 1 capmatinib 1 aldesleukin 1 Standard of Care 1 Smoking Devices 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Practice Guidelines as Topic 1 Platinum 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡